Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3253032 | 0.98 | TP53 (0.33) | TP53KDM4ELMNACYP1A2 | |
| SCHEMBL4215424 | 0.95 | TP53 (0.32) | TP53KDM4ELMNACYP1A2 | |
| SCHEMBL6369496 | 0.95 | TP53 (0.32) | TP53KDM4ELMNACYP1A2 | |
| Hydrochloric Acid SCHEMBL28094809 | 0.95 | KDM4E (0.34) | TP53KDM4ELMNACYP1A2 | |
| SCHEMBL3975721 | 0.95 | TP53 (0.32) | TP53KDM4ELMNACYP1A2 | |
| SCHEMBL28048632 | 0.81 | LMNA (0.32) | KDM4ELMNACYP1A2 | |
| SCHEMBL1537296 | 0.79 | GRIN2D (0.33) | KDM4ELMNACYP1A2 | |
| SCHEMBL186138 | 0.79 | GRIN2D (0.33) | KDM4ELMNACYP1A2 | |
| SCHEMBL442281 | 0.78 | SLC7A5 (0.30) | — | |
| SCHEMBL288874 | 0.78 | NAAA (0.38) | TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090209642-A1 | Hydroxy Acid Complexes for Antiaging and Skin Renovation | BIODERM RESEARCH (US) | 2009-08-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209642-A1 | Hydroxy Acid Complexes for Antiaging and Skin Renovation | CUTA, SLC30A6, SLC30A7 | TP53 339/4885KDM4E 3320/4885LMNA 3195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.